BioNexus Gene Lab board approves Ethereum-focused treasury strategy, first Nasdaq-listed company to do so

BioNexus Gene Lab Corp

Board approved Ethereum (ETH) as the primary treasury asset; BGLC is first Nasdaq-listed company to do so.
Cites Ethereum's institutional credibility, staking yield, stablecoin dominance, and upcoming Pectra upgrade.
Released Ethereum Strategy Whitepaper publicly on company website.
Company incorporated in Wyoming, which has pro-blockchain regulations; Wyoming Stable Token Act cited.
CEO Sam Tan says Ethereum treasury strategy enhances financial resilience and attracts forward-thinking investors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.